{"id":4294,"date":"2021-07-28T14:29:07","date_gmt":"2021-07-28T13:29:07","guid":{"rendered":"https:\/\/ksapa.org\/fr\/?page_id=4294"},"modified":"2025-01-12T18:01:23","modified_gmt":"2025-01-12T17:01:23","slug":"roche-pharma-lanalyse-de-materialite-au-coeur-de-la-rse","status":"publish","type":"page","link":"https:\/\/ksapa.org\/fr\/a-propos\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\/roche-pharma-lanalyse-de-materialite-au-coeur-de-la-rse\/","title":{"rendered":"Roche Pharma : L&rsquo;analyse de mat\u00e9rialit\u00e9 au c\u0153ur de la RSE"},"content":{"rendered":"\n\n  <div class=\"banner has-hover\" id=\"banner-1105670095\">\n          <div class=\"banner-inner fill\">\n        <div class=\"banner-bg fill\" >\n            <div class=\"bg fill bg-fill \"><\/div>\n                        <div class=\"overlay\"><\/div>            \n                    <\/div>\n        <div class=\"banner-layers container\">\n            <div class=\"fill banner-link\"><\/div>            \n\n   <div id=\"text-box-1511582462\" class=\"text-box banner-layer x50 md-x50 lg-x50 y80 md-y50 lg-y50 res-text\">\n                                <div class=\"text-box-content text dark\">\n              \n              <div class=\"text-inner text-center\">\n                  \n\n<h1 class=\"uppercase\"><strong>ROCHE PHARMA<\/strong><\/h1>\n<div class=\"is-divider divider clearfix\" style=\"background-color:rgb(255, 255, 255);\"><\/div>\n\n<h2 class=\"uppercase\">L&rsquo;analyse de mat\u00e9rialit\u00e9 au c\u0153ur de la RSE<\/h2>\n\n              <\/div>\n           <\/div>\n                            \n<style>\n#text-box-1511582462 {\n  width: 60%;\n}\n#text-box-1511582462 .text-box-content {\n  font-size: 100%;\n}\n<\/style>\n    <\/div>\n \n\n        <\/div>\n      <\/div>\n\n            \n<style>\n#banner-1105670095 {\n  padding-top: 350px;\n}\n#banner-1105670095 .bg.bg-loaded {\n  background-image: url(https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2021\/07\/pexels-chokniti-khongchum-3938023-1-scaled.jpg);\n}\n#banner-1105670095 .overlay {\n  background-color: rgba(0,0,0,.5);\n}\n#banner-1105670095 .bg {\n  background-position: 71% 19%;\n}\n<\/style>\n  <\/div>\n\n\n\t<section class=\"section\" id=\"section_82173782\">\n\t\t<div class=\"bg section-bg fill bg-fill  bg-loaded\" >\n\n\t\t\t\n\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n\n<div class=\"row\"  id=\"row-515218955\">\n\n\n\t<div id=\"col-2068485311\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n\t<div class=\"img has-hover x md-x lg-x y md-y lg-y\" id=\"image_72188536\">\n\t\t\t\t\t\t\t\t<div class=\"img-inner dark\" >\n\t\t\t<img decoding=\"async\" width=\"1020\" height=\"267\" src=\"https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2021\/08\/Citation-RP-FR-1-1400x367.jpg\" class=\"attachment-large size-large\" alt=\"Nell Gu\u00e9ho CSR strategy transition manager Roche Pharma France - Citation client Ksapa\" srcset=\"https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2021\/08\/Citation-RP-FR-1-1400x367.jpg 1400w, https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2021\/08\/Citation-RP-FR-1-800x210.jpg 800w, https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2021\/08\/Citation-RP-FR-1-768x201.jpg 768w, https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2021\/08\/Citation-RP-FR-1-1536x403.jpg 1536w, https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2021\/08\/Citation-RP-FR-1.jpg 1656w\" sizes=\"(max-width: 1020px) 100vw, 1020px\" \/>\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\n<style>\n#image_72188536 {\n  width: 100%;\n}\n<\/style>\n\t<\/div>\n\t\n\n<p class=\"lead\" style=\"text-align: center;\">D\u00e9couvrez comment Ksapa a guid\u00e9 Roche Pharma France dans l&rsquo;\u00e9laboration de sa strat\u00e9gie RSE via l&rsquo;analyse de mat\u00e9rialit\u00e9<\/p>\n<h2 class=\"uppercase\" style=\"text-align: left;\">LES OBJECTIFS D&rsquo;ENGAGEMENTS<\/h2>\n<p style=\"text-align: left;\">Les parties prenantes demandent de plus en plus aux organisations de d\u00e9montrer leur capacit\u00e9 \u00e0 concevoir et \u00e0 mettre en \u0153uvre une strat\u00e9gie responsable et durable tout au long de leur cha\u00eene de valeur. Il se trouve que cet \u00e9cosyst\u00e8me de parties prenantes est particuli\u00e8rement bien inform\u00e9 et engag\u00e9&#8230;<\/p>\n<p style=\"text-align: left;\">En vue du d\u00e9ploiement d&rsquo;une nouvelle strat\u00e9gie de responsabilit\u00e9 socio-environnementale, le responsable de la transition de Roche Pharma a fait appel \u00e0 Ksapa pour r\u00e9aliser une analyse de mat\u00e9rialit\u00e9. L&rsquo;objectif \u00e9tait de mieux identifier les enjeux extra-financiers de la filiale de Roche Pharma en France, en coh\u00e9rence avec ses orientations strat\u00e9giques sp\u00e9cifiques, ses lignes directrices en mati\u00e8re de reporting et les attentes de ses parties prenantes prioritaires.\u00a0<\/p>\n<p style=\"text-align: left;\">Outil privil\u00e9gi\u00e9 par 63% des entreprises, l&rsquo;analyse de mat\u00e9rialit\u00e9 est un \u00e9l\u00e9ment cl\u00e9 pour structurer et valoriser ces engagements.\u00a0<\/p>\n<h2 class=\"uppercase\" style=\"text-align: left;\">aborder la collaboration\u00a0<\/h2>\n<p style=\"text-align: left;\">S&rsquo;appuyant sur les sp\u00e9cificit\u00e9s du secteur pharmaceutique, Ksapa a men\u00e9 une r\u00e9flexion approfondie sur les objectifs prioritaires de Roche Pharma France.<\/p>\n<ol style=\"text-align: left;\">\n<li>Une \u00e9quipe de consultants tr\u00e8s soud\u00e9e a r\u00e9alis\u00e9 <strong>une cartographie compl\u00e8te des enjeux, des risques et des parties prenantes de Roche Pharma France.<\/strong> Un total de 49 enjeux a \u00e9t\u00e9 identifi\u00e9 et r\u00e9parti en 11 cat\u00e9gories prioritaires. Ces enjeux non financiers ont \u00e9t\u00e9 calibr\u00e9s sur la base d&rsquo;une liste fournie par Ksapa. Celle-ci s&rsquo;est inspir\u00e9e de diff\u00e9rents cadres internationaux, des ODD \u00e0 l&rsquo;Indice d&rsquo;acc\u00e8s aux m\u00e9dicaments, du GRI Healthcare 45 en passant par la D\u00e9claration de performance extra-financi\u00e8re, la loi Grenelle 2, la directive RSE et le DJSI&#8230; Ksapa a encore renforc\u00e9 son analyse par un examen des plans d&rsquo;action et des indicateurs internes. L&rsquo;\u00e9quipe a tenu \u00e0 assurer la coh\u00e9rence avec la terminologie du Groupe, afin de favoriser l&rsquo;alignement interne autour d&rsquo;une \u00e9valuation consensuelle des questions cl\u00e9s.<\/li>\n<li>Sur la base de cette phase initiale de documentation, Ksapa a consolid\u00e9 son analyse par le biais <strong>d&rsquo;entretiens avec des parties prenantes internes et externes<\/strong>. L&rsquo;\u00e9quipe a contact\u00e9 20 parties prenantes internes, dont l&rsquo;ensemble du Comit\u00e9 ex\u00e9cutif, des praticiens strat\u00e9giques et op\u00e9rationnels du Groupe ainsi que des employ\u00e9s. Ce retour d&rsquo;information a \u00e9t\u00e9 compl\u00e9t\u00e9 par les perspectives de 21 parties prenantes externes, allant des professionnels de la sant\u00e9 aux associations de patients, en passant par les \u00e9conomistes de la sant\u00e9, les experts, les m\u00e9dias et autres influenceurs.<\/li>\n<li>Enfin, Ksapa a \u00e9labor\u00e9<strong> une matrice de mat\u00e9rialit\u00e9<\/strong>. Nous avons crois\u00e9 et compar\u00e9 les r\u00e9sultats initiaux dans le cadre de divers ateliers internes. De cette fa\u00e7on, nous avons triangul\u00e9 toutes les priorit\u00e9s de Roche Pharma France par rapport aux orientations strat\u00e9giques du Groupe et aux attentes des parties prenantes. Nous avons finalement hi\u00e9rarchis\u00e9 les questions essentielles selon qu&rsquo;elles pr\u00e9sentaient un risque ou une opportunit\u00e9 pour Roche Pharma France \u00e0 moyen ou long terme. Ces enjeux allaient de l&rsquo;acc\u00e8s aux soins \u00e0 l&rsquo;innovation th\u00e9rapeutique et \u00e0 la m\u00e9decine personnalis\u00e9e, etc.<\/li>\n<\/ol>\n<p style=\"text-align: left;\">Les recommandations de Ksapa ont \u00e9t\u00e9 renforc\u00e9es par un<strong> examen critique des signaux \u00e9mergents<\/strong>, tels que l&rsquo;\u00e9conomie circulaire, l&rsquo;engagement des parties prenantes, l&rsquo;innovation et l&rsquo;excellence manag\u00e9riale, la gestion du capital humain, etc. Nous avons ajout\u00e9 une <strong>analyse des tendances cl\u00e9s pour les trois prochaines ann\u00e9es,<\/strong> en r\u00e9fl\u00e9chissant notamment \u00e0 la cr\u00e9ation de valeur partag\u00e9e, au d\u00e9veloppement territorial, aux risques environnementaux ainsi qu&rsquo;\u00e0 l&rsquo;alignement de la proposition de valeur du Groupe avec les consid\u00e9rations \u00e9thiques d&rsquo;un monde en mutation, etc.<\/p>\n<h2 class=\"uppercase\" style=\"text-align: left;\">R\u00e9SULTATS ET PROCHAINES \u00e9TAPES\u00a0<\/h2>\n<p style=\"text-align: left;\">Cette matrice de mat\u00e9rialit\u00e9 a fourni \u00e0 Roche Pharma France des informations cl\u00e9s pour la d\u00e9finition d&rsquo;une feuille de route pertinente, align\u00e9e sur son plan strat\u00e9gique plus large. L&rsquo;analyse qui en a r\u00e9sult\u00e9 a simplifi\u00e9 la visualisation des questions essentielles, de leur importance et de leurs interconnexions. Cela a permis \u00e0 l&rsquo;\u00e9quipe RSE de Roche Pharma d&rsquo;aborder les priorit\u00e9s strat\u00e9giques et les attentes des parties prenantes.<\/p>\n<p style=\"text-align: left;\">Cette approche a \u00e9galement aid\u00e9 le personnel du groupe \u00e0 communiquer les messages prioritaires dans le contexte du dialogue permanent avec les parties prenantes. En fin de compte, cette approche a permis \u00e0 Roche Pharma France d&rsquo;anticiper les risques potentiels et de s\u00e9curiser sa licence d&rsquo;exploitation \u00e0 la lumi\u00e8re des activit\u00e9s actuellement sensibles.\u00a0 \u00a0<\/p>\n<h3 class=\"uppercase\" style=\"text-align: left;\">Pr\u00eat \u00e0 renforcer votre strat\u00e9gie RSE ?<\/h3>\n<p style=\"text-align: left;\">Contactez nos experts Ksapa pour r\u00e9aliser votre analyse de mat\u00e9rialit\u00e9 et construire une feuille de route RSE adapt\u00e9e \u00e0 vos enjeux: contact@ksapa.org<\/p>\n<div class=\"row\"  id=\"row-316384628\">\n\n\n\t<div id=\"col-693357739\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n<div class=\"text-center\"><div class=\"is-divider divider clearfix\" ><\/div><\/div>\n\n<h2>A propos de Roche Pharma<\/h2>\n<div class=\"row\"  id=\"row-381833549\">\n\n\n\t<div id=\"col-338991842\" class=\"col medium-8 small-12 large-8\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n<p>Roche Pharmaceuticals a pour objectif de traduire l&rsquo;excellence scientifique en m\u00e9dicaments efficaces pour les patients. Elle associe la recherche de pointe men\u00e9e par Roche, Genentech aux \u00c9tats-Unis, Chugai au Japon et plus de 150 partenaires dans le monde entier, \u00e0 une \u00e9chelle et une port\u00e9e mondiales en mati\u00e8re de d\u00e9veloppement clinique, de fabrication et d&rsquo;op\u00e9rations commerciales. Gr\u00e2ce au vaste portefeuille de la division Pharma, Roche est l&rsquo;un des principaux fournisseurs mondiaux de m\u00e9dicaments cliniquement diff\u00e9renci\u00e9s.<\/p>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t<div id=\"col-1575842983\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n\t<div class=\"img has-hover x md-x lg-x y md-y lg-y\" id=\"image_1093378734\">\n\t\t\t\t\t\t\t\t<div class=\"img-inner dark\" >\n\t\t\t<img decoding=\"async\" width=\"740\" height=\"416\" src=\"https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2021\/07\/pha_overview_740px.jpg\" class=\"attachment-large size-large\" alt=\"\" srcset=\"https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2021\/07\/pha_overview_740px.jpg 740w, https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2021\/07\/pha_overview_740px-712x400.jpg 712w\" sizes=\"(max-width: 740px) 100vw, 740px\" \/>\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\n<style>\n#image_1093378734 {\n  width: 100%;\n}\n<\/style>\n\t<\/div>\n\t\n\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n<\/div>\n<h2>En savoir plus<\/h2>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n<\/div>\n<div class=\"row\"  id=\"row-249062350\">\n\n\n\t<div id=\"col-1463435102\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n<h3 style=\"text-align: center\"><a href=\"https:\/\/ksapa.org\/fr\/mobiliser\/blog\/\">Article de blog<\/a><\/h3>\n\n  <div class=\"banner has-hover bg-zoom\" id=\"banner-1073899059\">\n          <div class=\"banner-inner fill\">\n        <div class=\"banner-bg fill\" >\n            <div class=\"bg fill bg-fill \"><\/div>\n                        <div class=\"overlay\"><\/div>            \n                    <\/div>\n        <div class=\"banner-layers container\">\n            <div class=\"fill banner-link\"><\/div>            \n\n   <div id=\"text-box-328100991\" class=\"text-box banner-layer x50 md-x50 lg-x50 y50 md-y50 lg-y50 res-text\">\n                                <div class=\"text-box-content text dark\">\n              \n              <div class=\"text-inner text-center\">\n                  \n\n<h2 class=\"thin-font\"><a href=\"https:\/\/ksapa.org\/fr\/comprendre-le-concept-de-double-materialite\/\">Comprendre le concept de la double mat\u00e9rialit\u00e9<\/a><\/h2>\n<a href=\"https:\/\/ksapa.org\/fr\/comprendre-le-concept-de-double-materialite\/\" target=\"_self\" class=\"button white is-outline\"  >\n    <span>Lire la suite<\/span>\n  <\/a>\n\n\n\n              <\/div>\n           <\/div>\n                            \n<style>\n#text-box-328100991 {\n  width: 60%;\n}\n#text-box-328100991 .text-box-content {\n  font-size: 100%;\n}\n<\/style>\n    <\/div>\n \n\n        <\/div>\n      <\/div>\n\n            \n<style>\n#banner-1073899059 {\n  padding-top: 250px;\n}\n#banner-1073899059 .bg.bg-loaded {\n  background-image: url(https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2021\/08\/Ksapa-Briefing-Paper-Understanding-the-Concept-of-Double-Materiality-1-567x400.jpg);\n}\n#banner-1073899059 .overlay {\n  background-color: rgba(0,0,0,.5);\n}\n<\/style>\n  <\/div>\n\n\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t<div id=\"col-669219023\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n<h3 style=\"text-align: center\">Nos services<\/h3>\n\n  <div class=\"banner has-hover bg-zoom\" id=\"banner-842420148\">\n          <div class=\"banner-inner fill\">\n        <div class=\"banner-bg fill\" >\n            <div class=\"bg fill bg-fill \"><\/div>\n                        <div class=\"overlay\"><\/div>            \n                    <\/div>\n        <div class=\"banner-layers container\">\n            <a class=\"fill\" href=\"https:\/\/ksapa.org\/fr\/conseiller\/conseil-en-durabilite\/\"  ><div class=\"fill banner-link\"><\/div><\/a>            \n\n   <div id=\"text-box-1726814830\" class=\"text-box banner-layer x50 md-x50 lg-x50 y50 md-y50 lg-y50 res-text\">\n                                <div class=\"text-box-content text dark\">\n              \n              <div class=\"text-inner text-center\">\n                  \n\n<h2 class=\"uppercase\"><a href=\"https:\/\/ksapa.org\/fr\/conseiller\/conseil-en-durabilite\/\">CONSEIL EN DURABILIT\u00e9<\/a><\/h2>\n\n              <\/div>\n           <\/div>\n                            \n<style>\n#text-box-1726814830 {\n  width: 60%;\n}\n#text-box-1726814830 .text-box-content {\n  font-size: 100%;\n}\n<\/style>\n    <\/div>\n \n\n        <\/div>\n      <\/div>\n\n            \n<style>\n#banner-842420148 {\n  padding-top: 250px;\n}\n#banner-842420148 .bg.bg-loaded {\n  background-image: url(https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2020\/11\/pexels-startup-stock-photos-212286-600x400.jpg);\n}\n#banner-842420148 .overlay {\n  background-color: rgba(0,0,0,.5);\n}\n<\/style>\n  <\/div>\n\n\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t<div id=\"col-1853282876\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n    <div class=\"box has-hover has-hover box-text-bottom\" >\n\n                  <div class=\"box-image \" style=\"width:45%;\">\n           <div class=\"box-image-inner image-cover\" style=\"border-radius:100%;padding-top:100%;\">\n              <img decoding=\"async\" width=\"1500\" height=\"1500\" src=\"https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2019\/10\/christian-chateauvieux-RSE-small.jpg\" class=\"attachment- size-\" alt=\"Christian Chateauvieux - Ksapa\" srcset=\"https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2019\/10\/christian-chateauvieux-RSE-small.jpg 1500w, https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2019\/10\/christian-chateauvieux-RSE-small-280x280.jpg 280w, https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2019\/10\/christian-chateauvieux-RSE-small-400x400.jpg 400w, https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2019\/10\/christian-chateauvieux-RSE-small-768x768.jpg 768w, https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2019\/10\/christian-chateauvieux-RSE-small-800x800.jpg 800w\" sizes=\"(max-width: 1500px) 100vw, 1500px\" \/>                         <\/div>\n          <\/div>\n         \n          <div class=\"box-text text-center\" >\n                <div class=\"box-text-inner\">\n                  <h4 class=\"uppercase\">\n                    <span class=\"person-name\">Christian Chateauvieux<\/span><br\/>\n                    <span class=\"person-title is-small thin-font op-7\">\n                      IT SOLUTIONS AND SUSTAINABILITY MANAGER                    <\/span>\n                  <\/h4>\n                                  \n\n<a href=\"https:\/\/ksapa.org\/fr\/impliquez-vous\/contact\/\" target=\"_self\" class=\"button primary is-outline\"  style=\"border-radius:99px;\">\n    <span>CONTACTEZ NOUS<\/span>\n  <\/a>\n\n\n\n                <\/div>\n          <\/div>\n    <\/div>\n\n    \n    \n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n<\/div>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n<\/div>\n<div class=\"row align-center\"  id=\"row-1714244892\">\n\n\n\t<div id=\"col-1892647182\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner text-center\"  >\n\t\t\t\n\t\t\t\n\n<a href=\"https:\/\/ksapa.org\/fr\/a-propos\/nos-etudes-de-cas\/\" target=\"_self\" class=\"button primary lowercase\"  style=\"border-radius:99px;\">\n    <span>Nos \u00e9tudes de cas<\/span>\n  <\/a>\n\n\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n<\/div>\n\n\t\t<\/div>\n\n\t\t\n<style>\n#section_82173782 {\n  padding-top: 30px;\n  padding-bottom: 30px;\n}\n<\/style>\n\t<\/section>\n\t\n\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":70,"featured_media":4272,"parent":3335,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-blank.php","meta":{"footnotes":""},"class_list":["post-4294","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Roche Pharma : L&#039;analyse de mat\u00e9rialit\u00e9 au c\u0153ur de la RSE<\/title>\n<meta name=\"description\" content=\"Ksapa a accompagn\u00e9 Roche Pharma dans un exercice de mat\u00e9rialit\u00e9 permettant de rafraichir la strat\u00e9gie RSE.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ksapa.org\/fr\/a-propos\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\/roche-pharma-lanalyse-de-materialite-au-coeur-de-la-rse\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Roche Pharma : L&#039;analyse de mat\u00e9rialit\u00e9 au c\u0153ur de la RSE\" \/>\n<meta property=\"og:description\" content=\"Ksapa a accompagn\u00e9 Roche Pharma dans un exercice de mat\u00e9rialit\u00e9 permettant de rafraichir la strat\u00e9gie RSE.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ksapa.org\/fr\/a-propos\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\/roche-pharma-lanalyse-de-materialite-au-coeur-de-la-rse\/\" \/>\n<meta property=\"og:site_name\" content=\"Ksapa - fr\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-12T17:01:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2021\/07\/pexels-chokniti-khongchum-3938023-1-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1709\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@KsapaOrg\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/a-propos\\\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\\\/roche-pharma-lanalyse-de-materialite-au-coeur-de-la-rse\\\/\",\"url\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/a-propos\\\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\\\/roche-pharma-lanalyse-de-materialite-au-coeur-de-la-rse\\\/\",\"name\":\"Roche Pharma : L'analyse de mat\u00e9rialit\u00e9 au c\u0153ur de la RSE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/a-propos\\\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\\\/roche-pharma-lanalyse-de-materialite-au-coeur-de-la-rse\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/a-propos\\\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\\\/roche-pharma-lanalyse-de-materialite-au-coeur-de-la-rse\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/wp-content\\\/uploads\\\/sites\\\/1\\\/2021\\\/07\\\/pexels-chokniti-khongchum-3938023-1-scaled.jpg\",\"datePublished\":\"2021-07-28T13:29:07+00:00\",\"dateModified\":\"2025-01-12T17:01:23+00:00\",\"description\":\"Ksapa a accompagn\u00e9 Roche Pharma dans un exercice de mat\u00e9rialit\u00e9 permettant de rafraichir la strat\u00e9gie RSE.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/a-propos\\\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\\\/roche-pharma-lanalyse-de-materialite-au-coeur-de-la-rse\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ksapa.org\\\/fr\\\/a-propos\\\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\\\/roche-pharma-lanalyse-de-materialite-au-coeur-de-la-rse\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/a-propos\\\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\\\/roche-pharma-lanalyse-de-materialite-au-coeur-de-la-rse\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/wp-content\\\/uploads\\\/sites\\\/1\\\/2021\\\/07\\\/pexels-chokniti-khongchum-3938023-1-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/wp-content\\\/uploads\\\/sites\\\/1\\\/2021\\\/07\\\/pexels-chokniti-khongchum-3938023-1-scaled.jpg\",\"width\":2560,\"height\":1709,\"caption\":\"D\u00e9couvrez comment Ksapa a guid\u00e9 Roche Pharma France dans l'\u00e9laboration de sa strat\u00e9gie RSE via l'analyse de mat\u00e9rialit\u00e9\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/a-propos\\\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\\\/roche-pharma-lanalyse-de-materialite-au-coeur-de-la-rse\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u00c0 propos\",\"item\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/a-propos\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Etudes de cas\",\"item\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/a-propos\\\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Roche Pharma : L&rsquo;analyse de mat\u00e9rialit\u00e9 au c\u0153ur de la RSE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/\",\"name\":\"Ksapa - fr\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/#organization\",\"name\":\"ksapa\",\"url\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/wp-content\\\/uploads\\\/sites\\\/1\\\/2019\\\/06\\\/icone-ksapa.jpg\",\"contentUrl\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/wp-content\\\/uploads\\\/sites\\\/1\\\/2019\\\/06\\\/icone-ksapa.jpg\",\"width\":\"442\",\"height\":\"421\",\"caption\":\"ksapa\"},\"image\":{\"@id\":\"https:\\\/\\\/ksapa.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/KsapaOrg\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Roche Pharma : L'analyse de mat\u00e9rialit\u00e9 au c\u0153ur de la RSE","description":"Ksapa a accompagn\u00e9 Roche Pharma dans un exercice de mat\u00e9rialit\u00e9 permettant de rafraichir la strat\u00e9gie RSE.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ksapa.org\/fr\/a-propos\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\/roche-pharma-lanalyse-de-materialite-au-coeur-de-la-rse\/","og_locale":"fr_FR","og_type":"article","og_title":"Roche Pharma : L'analyse de mat\u00e9rialit\u00e9 au c\u0153ur de la RSE","og_description":"Ksapa a accompagn\u00e9 Roche Pharma dans un exercice de mat\u00e9rialit\u00e9 permettant de rafraichir la strat\u00e9gie RSE.","og_url":"https:\/\/ksapa.org\/fr\/a-propos\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\/roche-pharma-lanalyse-de-materialite-au-coeur-de-la-rse\/","og_site_name":"Ksapa - fr","article_modified_time":"2025-01-12T17:01:23+00:00","og_image":[{"width":2560,"height":1709,"url":"https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2021\/07\/pexels-chokniti-khongchum-3938023-1-scaled.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@KsapaOrg","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ksapa.org\/fr\/a-propos\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\/roche-pharma-lanalyse-de-materialite-au-coeur-de-la-rse\/","url":"https:\/\/ksapa.org\/fr\/a-propos\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\/roche-pharma-lanalyse-de-materialite-au-coeur-de-la-rse\/","name":"Roche Pharma : L'analyse de mat\u00e9rialit\u00e9 au c\u0153ur de la RSE","isPartOf":{"@id":"https:\/\/ksapa.org\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ksapa.org\/fr\/a-propos\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\/roche-pharma-lanalyse-de-materialite-au-coeur-de-la-rse\/#primaryimage"},"image":{"@id":"https:\/\/ksapa.org\/fr\/a-propos\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\/roche-pharma-lanalyse-de-materialite-au-coeur-de-la-rse\/#primaryimage"},"thumbnailUrl":"https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2021\/07\/pexels-chokniti-khongchum-3938023-1-scaled.jpg","datePublished":"2021-07-28T13:29:07+00:00","dateModified":"2025-01-12T17:01:23+00:00","description":"Ksapa a accompagn\u00e9 Roche Pharma dans un exercice de mat\u00e9rialit\u00e9 permettant de rafraichir la strat\u00e9gie RSE.","breadcrumb":{"@id":"https:\/\/ksapa.org\/fr\/a-propos\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\/roche-pharma-lanalyse-de-materialite-au-coeur-de-la-rse\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ksapa.org\/fr\/a-propos\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\/roche-pharma-lanalyse-de-materialite-au-coeur-de-la-rse\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ksapa.org\/fr\/a-propos\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\/roche-pharma-lanalyse-de-materialite-au-coeur-de-la-rse\/#primaryimage","url":"https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2021\/07\/pexels-chokniti-khongchum-3938023-1-scaled.jpg","contentUrl":"https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2021\/07\/pexels-chokniti-khongchum-3938023-1-scaled.jpg","width":2560,"height":1709,"caption":"D\u00e9couvrez comment Ksapa a guid\u00e9 Roche Pharma France dans l'\u00e9laboration de sa strat\u00e9gie RSE via l'analyse de mat\u00e9rialit\u00e9"},{"@type":"BreadcrumbList","@id":"https:\/\/ksapa.org\/fr\/a-propos\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\/roche-pharma-lanalyse-de-materialite-au-coeur-de-la-rse\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ksapa.org\/fr\/"},{"@type":"ListItem","position":2,"name":"\u00c0 propos","item":"https:\/\/ksapa.org\/fr\/a-propos\/"},{"@type":"ListItem","position":3,"name":"Etudes de cas","item":"https:\/\/ksapa.org\/fr\/a-propos\/etudes-de-cas-du-defi-esg-vers-la-transformation-odd-durable\/"},{"@type":"ListItem","position":4,"name":"Roche Pharma : L&rsquo;analyse de mat\u00e9rialit\u00e9 au c\u0153ur de la RSE"}]},{"@type":"WebSite","@id":"https:\/\/ksapa.org\/fr\/#website","url":"https:\/\/ksapa.org\/fr\/","name":"Ksapa - fr","description":"","publisher":{"@id":"https:\/\/ksapa.org\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ksapa.org\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ksapa.org\/fr\/#organization","name":"ksapa","url":"https:\/\/ksapa.org\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ksapa.org\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2019\/06\/icone-ksapa.jpg","contentUrl":"https:\/\/ksapa.org\/fr\/wp-content\/uploads\/sites\/1\/2019\/06\/icone-ksapa.jpg","width":"442","height":"421","caption":"ksapa"},"image":{"@id":"https:\/\/ksapa.org\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/KsapaOrg"]}]}},"_links":{"self":[{"href":"https:\/\/ksapa.org\/fr\/wp-json\/wp\/v2\/pages\/4294","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ksapa.org\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ksapa.org\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ksapa.org\/fr\/wp-json\/wp\/v2\/users\/70"}],"replies":[{"embeddable":true,"href":"https:\/\/ksapa.org\/fr\/wp-json\/wp\/v2\/comments?post=4294"}],"version-history":[{"count":21,"href":"https:\/\/ksapa.org\/fr\/wp-json\/wp\/v2\/pages\/4294\/revisions"}],"predecessor-version":[{"id":10035,"href":"https:\/\/ksapa.org\/fr\/wp-json\/wp\/v2\/pages\/4294\/revisions\/10035"}],"up":[{"embeddable":true,"href":"https:\/\/ksapa.org\/fr\/wp-json\/wp\/v2\/pages\/3335"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ksapa.org\/fr\/wp-json\/wp\/v2\/media\/4272"}],"wp:attachment":[{"href":"https:\/\/ksapa.org\/fr\/wp-json\/wp\/v2\/media?parent=4294"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}